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Abstract 
 
Background: The Socio-Technical Allocation of Resources (STAR) has been developed for value 
for money analysis of health services through stakeholder workshops. This paper reports on its 
application for prioritisation of interventions within public health programmes.  
 
Methods: The STAR tool was used by identifying costs and service activity for interventions within 
commissioned public health programmes, with benefits estimated from the literature on economic 
evaluations in terms of costs per Quality-Adjusted Life Years (QALYs); consensus on how these 
QALY values applied to local services was obtained with local commissioners. 
 
Results: Local cost-effectiveness estimates could be made for some interventions. Methodological 
issues arose from gaps in the evidence base for other interventions, inability to closely match some 
performance monitoring data with interventions, and disparate time horizons of published QALY 
data. Practical adjustment for these issues included using population prevalences and utility states 
where intervention specific evidence was lacking, and subdivision of large contracts into specific 
intervention costs using staffing ratios. The STAR approach proved useful in informing 
commissioning decisions and understanding the relative value of local public health interventions 
 
Conclusions:. Further work is needed to improve robustness of the process and develop a 
visualisation tool for use by public health departments. 
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Background  
 
Following the Health and Social Care Act 2012 most public health functions moved from Primary 
Care Trusts to Local Authorities in April 2013. Following this public health funding has come under 
threat both from the Council wide efficiencies as part of the Government’s debt reduction policy 
and further in-year cuts to Public Health in 2015 (1). For Wakefield Local Authority this equated an 
estimated 20% reduction in the money available to commission public health services between 
2015 and 2020. This has placed pressure on the Council’s ability to fulfil its statutory public health 
responsibilities at previous levels of service delivery (2). 
 
To help minimise the population health impact of spending decisions a clear and transparent 
prioritisation process was designed. This was based on public health outcomes, population need, 
equity of access, current provider performance, best evidence and value for money. It also 
encompassed the political, financial and reputational risks around re-commissioning with a reduced 
budget. The process encompassed three distinct stages.  
 
1. Firstly, public health spend was divided into ten commissioning programmes (e.g. obesity, 
tobacco, sexual health) and their relative importance was ranked using multi-criteria 
decision analysis. 
2. Secondly, each programme was reviewed separately using the Socio-Technical Allocation 
of Resources (STAR) Tool (3) in order to visualise cost effectiveness of elements of each 
programme and provide recommendations to maximise value for money. 
3. Following discussions based on the results of the multi-criteria decision analysis and STAR 
approach, public health commissioning intentions were determined for 2015-2020, with 
services either being re-commissioned, re-designed or de-commissioned.  
 
This paper reports on an experimental use of the STAR Tool for stage 2. STAR is an approach to 
informing value for money analysis of clinical services, which requires three basic sets of data on: 
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costs (fixed costs, costs per case, and numbers of patients treated) and benefits (benefits of typical 
patients) and numbers who benefit from treatment. In STAR these basic sets of data are 
transformed by visual models into information that stakeholders can easily understand.   
 
In STAR there are three visual models for each component of the care pathway: rectangles of total 
costs (fixed and variable); rectangles of total benefits; and value triangles (Figure 1). In the value 
triangle total costs are on the horizontal axis, total benefits on the vertical axis, and value on the 
hypotenuse (i.e. the slope, which gives ratio of benefits to costs). This visual model makes clear 
that components with steep and shallow slopes are better and worse value respectively.  
 
 
 
 
 
 
 
STAR’s fourth visual model, the efficiency frontier, is generated by ordering value triangles in terms 
of their value (slope) for a given use of resources. Components with the highest value tend to be 
those at the start of the care pathway and those with the lowest value at the end. This allows 
illustration of the relative scale of different components in clinical care pathways in terms of their 
costs and benefits (4). Analytic and managerial effort can then be directed at how to reallocate 
resources to improve the value of those care pathways.  
 
 
 
 
Insert Figure 1 Here 
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STAR’s visual models are designed to be used as a basis for discussions on investment and dis-
investment.  These discussions could be based on either ranking or agreed threshold levels of the 
cost effectiveness. Sensitivity analyses around each estimate of local cost effectiveness ratio 
should also be undertaken to inform discussions as there are no definitive estimates of individual 
benefit. While it was originally developed as a tool for clinical services, recent financial challenges 
have presented an opportunity to adapt the tool for prioritisation of public health programmes. We 
report the results of our cost effectiveness analysis of public health services using the STAR Tool 
and the main methodological issues encountered. 
 
Methods 
 
We aimed to produce a STAR efficiency frontier for each of ten local public health programmes: 
sexual health, tobacco control, alcohol, substance misuse, physical activity, obesity, NHS Health 
checks, public mental health, oral health and domestic abuse. For this work a programme was 
defined as an area of commissioning spend covering one area of public health, including one or 
more services; a service was defined as a discrete public health activity with an associated cost. 
To produce an efficiency frontier, costs and benefits needed to be defined for each service within 
the chosen programme.  
 
Identification of Costs 
 
Costs were derived for all commissioned services within a programme from the most recent 
contract value. The cost of each service was averaged over a year and divided by the number of 
individuals accessing each service or component of a service to give an estimate of the cost per 
person. Where numbers accessing services were unavailable, estimates were made from the 
number of individuals offered the service, adjusted by an estimated take up rate. 
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Calculation of Benefit 
 
The design of the STAR Tool when used for analysis of clinical services involves a series of 
stakeholder workshops including commissioners, providers, clinicians and patients to determine 
the estimated individual benefit achieved for individuals benefiting from each intervention; this uses 
assessment of Quality of Life states before and after each intervention. Our experimental public 
health approach to STAR used a modified approach drawing on estimates of benefit in terms of 
Quality-Adjusted Life Years (QALYs) per person from interventions in the economic evaluation 
literature that were comparable to those delivered by the local services.  Where possible UK 
derived QALY estimates with a lifetime horizon were used (5).  These estimates were then 
multiplied by the numbers benefiting to identify the total benefit achieved locally for each service.  
 
Modelling of Uncertainty 
 
Following identification of the initial cost effectiveness estimates, a number of approaches were 
taken to ensure validity of findings. Discussions were held with the relevant local public health 
commissioners to identify whether the results reflected the effectiveness of the local intervention. In 
addition sensitivity analyses were undertaken by entering estimates for all interventions from the 
STAR Tool into a locally developed Microsoft Excel® tool; conservative and optimistic scenario 
estimates derived from halving and doubling the calculated estimate respectively for each 
intervention were plotted on a graph alongside the original intervention estimate to visualise the 
costs and benefits for public health spend for all the relevant commissioning programmes. 
Furthermore, individual cost effectiveness estimates were also triangulated with values from other 
health economic assessment tools for relevant interventions where possible (5).  
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Results 
 
During the application of the STAR tool a number of data problems were encountered, namely a 
lack of detailed contract information, a lack of relevant performance monitoring data, gaps in the 
health economic evidence base, and disparate time horizons. Of the ten public health programmes 
we attempted to model, cost and contract activity data could be sub-divided to allow mapping to 
evidence on the benefits of public health interventions for tobacco control, sexual health, alcohol 
and substance misuse, physical activity, obesity, NHS Health checks and domestic abuse. For 
mental health and oral health, contract data and published evidence were too mismatched to 
produce a STAR tool. We rep rt in detail on two of the programmes, the tobacco control 
programme and alcohol and substance misuse programme, but discuss issues encountered with 
respect to the eight programmes analysed. 
 
Contract activity data 
 
Where contract information was unavailable on the cost of individual components of a service, the 
overall contract was divided by: either the proportion of individuals receiving each component of a 
service, for example the numbers receiving opiate treatment as part of the substance misuse 
service; or the proportion of workforce time delivering each component of a service, for example 
the number of full time equivalent counsellors as a proportion of all staff within the domestic 
violence service. Where it was not possible to subdivide the cost of a service into the costs of the 
components because the latter were delivered simultaneously by one individual, for example the 
health checks, the service was considered as a single entity for the purposes of identifying costs. 
 
It was not straightforward to identify the number of individuals being offered or benefitting from 
some services where there was no directly related performance data, for example mass media 
campaigns around smoking cessation. For these, prevalence figures of the relevant sub group of 
the population being targeted were used as an estimate of numbers receiving the service, for 
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example the proportion of the local population smoking. For other services, an estimate of the 
number of individuals with a condition or behaviour potentially averted was calculated using local 
prevalence data and the latest national yearly increase in incidence of new cases. Other service 
outcome data was used where appropriate to derive estimates, for example trading standards data 
on illicit tobacco seizures was used to derive an estimate of individuals prevented from smoking. 
Where services aimed to train healthcare staff, an estimate was made of the proportion of the local 
population who would benefit as a result of that training, for example services seeking to educate 
primary care staff to better identify victims of domestic abuse. 
 
Benefit estimates  
 
We were not able to extract estimates of QALYs gained per person for some interventions, so the 
following model adjustments were made. Where there was no identifiable cost effectiveness 
estimate for a specific intervention but the evidence base suggested a lack of evidence of 
effectiveness, a near zero QALY value was used. Where there was no identifiable QALY per 
person value for a specific intervention but the evidence base suggested effectiveness, an 
estimate was derived by comparing lifetime QALYs lost for an individual with a condition to an 
individual without it, for example by comparing QALYs lost for a smoker versus a non-smoker and 
applying this to an estimated change in prevalence to find the total QALYS gained. Where a multi-
component service comprised a number of interventions, but there was no single QALY per person 
value for the service as a whole, an average QALY per person value was derived. For example, for 
the health checks service we identified local numbers of new diagnoses for each component of the 
service, and for each diagnosis used estimates of benefit as a result of appropriate further 
management of each from the literature to calculate an average individual benefit for the service as 
a whole. A similar approach was taken for a condom distribution programme, where the total 
number of QALYs gained was calculated based on the QALYs that would be lost for each infection 
that the condom distribution programme was likely to prevent.  
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Time horizon of benefits and costs 
 
Estimates of benefit based on a lifetime horizon were used as a gold standard. Where they were 
unavailable or the time horizon used for the estimate in the evidence base was different from the 
length of follow up for the service, adjustments were made; for example, estimates for weight loss 
interventions from the evidence were based on a lifetime horizon, so were reduced to reflect that 
the service outcomes were measured after three months. Where time horizons differed between 
services within a programme, adjustments were made to reflect lifetime benefit and allow 
comparisons between services. Whilst this was possible for tobacco control, since all services had 
essentially the same desired outcome of permanent quitting, it was not possible for all programmes 
due to the very different nature of the services within them; for example no adjustment was made 
to the estimate for the service aimed at improving the ability of primary care staff to identify 
domestic abuse to allow comparison with the estimate for the domestic abuse counselling service 
which used a different time horizon.  
 
Neither benefits nor costs were discounted over time as there is dispute between economists over 
what the discount rate should be and whether the same rate should be used for costs as well as 
benefits (6). The justification for discounting costs of commodities is that they reduce over time as 
economies become more productive, but as this justification does not apply to well-being, it has 
been argued that it is wrong to discount benefits in QALYs (7). It may also be inappropriate to 
discount costs of health services in austerity as it is unclear that these will be less burdensome in 
future, particularly given health services suffer from Baumol's disease  where labour intensive 
services become relatively more expensive over time (8). An alternative approach would have 
been to discount in line with NICE guidance at an annual rate of 1.5% or that of the United 
Kingdom treasury at 3.5%. 
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Tobacco Control Programme STAR Tool  
 
For the tobacco control programme there were four interventions or services: the specialist 
smoking cessation service, the GP delivered smoking cessation service, and contributions to both 
the West Yorkshire Mass Media Campaign and West Yorkshire Trading Standards, with the 
majority of the funding going to the specialist stop smoking service (Table 1). Mass media 
campaigns and trading standards were estimated to be the most cost effective investments, as 
they reach a far larger population despite having lower estimated benefits per person. GP 
delivered smoking cessation services were estimated to be more cost effective than specialist 
services despite a lower quit rate, as they have lower operating and fixed costs being delivered in-
house (Figure 2). 
 
 
 
Alcohol and Substance Misuse Programme 
 
For the alcohol and substance misuse programme there were five interventions or services: the 
alcohol and substance misuse treatment and recovery services for opiate use, non-opiate use and 
at-risk alcohol use, an alcohol liaison service, and a support service for parents and carers of those 
with alcohol and substance misuse issues (Table 1). Individual costs of the three treatment 
recovery services were unavailable as they were contained within a single integrated service so an 
assumption was made of equal costs per individual for each component. Opiate treatment and 
recovery accounted for three-quarters of the overall costs of the alcohol and substance misuse 
programme but a third of the estimated benefits. The non-opiate and alcohol addiction recovery 
services were estimated to be the most cost effective components (Figure 3). 
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Insert Table 1 Here 
 
 
Insert Figure 2 Here 
 
 
Insert Figure 3 Here 
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Discussion 
Main finding of this study 
 
This is the first use of the STAR approach to prioritise within public health programmes.  It has 
proved useful in informing commissioning decisions, strategic planning of future provision and 
engaging public health staff in key health economic principles. 
 
Local cost-effectiveness estimates could be made for most interventions, allowing comparison 
within and between programmes using visual methods. In general primary prevention interventions 
were the most cost effective, for example mass media campaigns and trading standards to reduce 
smoking compared to specialist stop smoking services. The visual demonstration of the STAR 
efficiency frontiers helped facilitate discussions on how to increase return on investment in the 
future. The health economic evidence gathered for this work also informed commissioners as to 
how a more targeted and stratified approach may improve the overall cost-effectiveness of the 
public health budget, for example priority target groups within a universal NHS Healthcheck 
programme. Furthermore, most of the local estimates suggested existing services provided value 
for money with average cost effectiveness ratios of below £15,000 per QALY.  
 
What is already known on this topic 
 
The STAR tool has previously been used to prioritise competing service bids (24), and to prioritise 
interventions treating patients with eating disorders (25) and chronic obstructive pulmonary disease  
(26). This modified “lean STAR” approach involving only public health commissioners gave further 
guidance at a local level about which particular interventions provided the greatest value for money 
and facilitated communication of this information through graphical means.  
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What this study adds 
 
This work should be seen within the context of the broader interdependencies of public 
health programmes and services. For example, STAR analysis often suggests, as in this 
case, that more ‘upstream’ primary prevention activities (e.g. education, campaigns, 
lifestyle interventions) are more cost-effective than treatment  (such as sexual health and 
opiate addiction treatment).  However it is simplistic to assume that this implies that the 
resources ought to be moved from the latter to the former because there is always a time lag 
from increasing primary prevention to reductions in needs for treatment; also the implications 
of not treating infections or addiction are serious as there is the potential to impact more 
widely on society (crime rates and secondary infections) and demand for other services (A&E 
attendances).  
 
What STAR does is to identify the scale of the resources allocated to different interventions 
and their benefits which may lead into identifying scope for less costly treatment of less 
severe cases that might enable resources to be released for primary prevention. Before any 
re-allocation of resources can occur, assessment of the broader interdependencies of public 
health services within the health, social care and community sector, and the political and 
contractual consequences is necessary, to avoid increasing need in other areas and passing 
costs to other agencies. Any decision making informed by STAR therefore requires careful 
planning and collaboration across the statutory and third sector, especially where there are 
no alternative services. 
 
Limitations of this study 
 
While STAR tools could be produced for most of the programmes, not all of them were sufficiently 
robust to be useful in informing decisions. Limitations were identified with respect to the variable 
evidence base, lack of clearly associated performance monitoring data, and disparate time 
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horizons. Methods were developed to adjust for these issues but ultimately decisions were made 
not to use some estimates: for the mental health programme, which was identified as a priority 
within the district, it was not possible to align the contract data with the published evidence base to 
inform future planning; for the sexual health programme, it was not possible to sub-divide the 
majority of the spend in a meaningful way against published QALY data. As this approach took 
only the commissioner perspective, the perspectives of provider organisations and service users 
might need consideration if the tool is to be used beyond an internal prioritisation exercise.  
 
The locally derived cost effectiveness estimates could also be strengthened by further modelling 
around uncertainty and developing a national online tool to assist local approaches. The latter 
should include evidence based value estimates for individual interventions, with the capacity to add 
locally derived activity and cost data; this would bring a broad health economic evidence base into 
a STAR visualisation tool for public health departments to adapt with local contract and cost data. 
Therefore, allowing for some limitations, this modified STAR approach has the potential to provide 
a useful health economic baseline to inform a broader public health prioritisation process and 
future commissioning arrangements.    
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Table 1: STAR Tool  Analysis for Two Programmes  
 
 
Service/ 
Intervention 
Cost of 
service per 
year 
Numbers offered 
service each year 
Estimated 
cost per 
person 
Estimated 
% who 
benefit 
Number benefiting 
each year 
Estimated benefit 
per person 
benefiting 
(QALYs) 
Total 
QALYs 
Tobacco Control Programme 
 
Specialist 
smoking 
cessation 
£774,000 2238  
(setting 4 week quit 
date, mean 2013-15) 
 
£345.85 9.2% 207 
(14%(8) of successful 4 
week quitters, mean 
2013-15) 
 
3 
(2.7(9),3.5 (10)) 
 
620 
GP delivered  
smoking 
cessation 
£91,000 1478  
(setting 4 week  quit 
date, mean 2013-15) 
 
£61.57 6.2% 91 
(14% (8) of successful 4 
week quitters, mean 
2013-15) 
 
3 
(2.7 (9),3.5 (10)) 
  
272 
Mass media 
campaign 
 
£50,000  
 
83,000 
(Wakefield 
population who 
smoke) 
 
£0.60 
 
0.4% 166 
(Based on 0.05% 
prevalence decrease in 
smoking prevalence 
0.3-1.1(11),0.44 (12),1.2 
(13),1.6% (14)) 
 
3 
(1.05 (15),2.7(9), 
3.5(10)) 
 
498 
Contribution 
to West 
Yorkshire 
Trading 
Standards 
 
£30,000  
 
83,000 
(Wakefield 
population who 
smoke) 
£0.36 0.04% 30 
(based on Wakefield 
proportional benefits 
(16)) 
3 
(2.7 (9),3.5(10)) 
 
90 
Page 21 of 43
http://jpubhealth.oupjournals.org
Manuscript Submitted to Journal of Public Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
Service/ 
Intervention 
Cost of 
service per 
year 
Numbers offered service 
each year  
Estimated 
cost per 
person 
Estimated 
% who 
benefit 
Number 
benefiting 
each year 
Estimated benefit 
per person 
benefiting (QALYs) 
Total 
QALYs  
Alcohol and Substance Misuse Programme 
Alcohol and 
substance 
misuse  
recovery 
service  
 
 
 
£4,057,347 
 
 
6548 
(commencing opiate 
treatment, mean 
2015/16) 
 
£524.21 6.2% 408 0.4  
(0.32-0.34 (17), 
0.68-0.71 (18)) 
 
163 
916 
(commencing non-opiate 
treatment, mean 2015/16) 
£524.21 50.7% 464 0.5 
(0.24-0.25 (18), 
0.25 (12), 
0.77-0.79 (15), 
0.38-0.39 (1)) 
 
232 
276 
(commencing alcohol 
treatment 
mean 2015/16) 
 
£524.21 94.2% 260 0.2  
(0.11-0.33 (19)) 
52 
Alcohol liaison 
service 
£95,000 
 
 
1400 
(given brief advice, mean 
2015/16) 
 
£67.86 100% 1400 0.02  
(0.0233 (20) 
0.004-0.018 (21)) 
 
28 
Relatives 
and 
carers 
support 
 
£70,000 
 
312 
(relatives supported, mean 
2015/16)) 
£224.36 100% 312 0.02  
(0.01 (22), 
0.02-0.03 (19)) 
6.3 
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Figure 2: Tobacco Control Programme Efficiency Frontier 
 
 
 
----   Specialist smoking cessation service 
----   GP delivered smoking cessation service 
----   Trading Standards contribution 
----   Mass media campaign contribution 
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Figure 3: Alcohol and Substance Misuse Programme Efficiency Frontier 
 
 
 
----   Voluntary sector addiction recovery non-opiates  
----   Voluntary sector addiction recovery alcohol 
----   Alcohol liaison service 
----   Relatives and carers support 
--- - Voluntary sector addiction recovery opiates 
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Abstract 
 
Background: The Socio-Technical Allocation of Resources (STAR) has been developed for value 
for money analysis of health services through stakeholder workshops. This paper reports on its 
application for prioritisation of interventions within public health programmes.  
 
Methods: The STAR tool was used by identifying costs and service activity for interventions within 
commissioned public health programmes, with benefits estimated from the literature on economic 
evaluations in terms of costs per Quality-Adjusted Life Years (QALYs); consensus on how these 
QALY values applied to local services was obtained with local commissioners. 
 
Results: Local cost-effectiveness estimates could be made for some interventions. Methodological 
issues arose from gaps in the evidence base for other interventions, inability to closely match some 
performance monitoring data with interventions, and disparate time horizons of published QALY 
data. Practical adjustment for these issues included using population prevalences and utility states 
where intervention specific evidence was lacking, and subdivision of large contracts into specific 
intervention costs using staffing ratios. The STAR approach proved useful in informing 
commissioning decisions and understanding the relative value of local public health interventions 
 
Conclusions: The STAR approach proved useful in informing commissioning decisions and 
understanding the relative value of local public health interventions. Further work is needed to 
improve robustness of the process and develop a visualisation tool for use by public health 
departments. 
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Background  
 
Following the Health and Social Care Act 2012 most public health functions moved from Primary 
Care Trusts to Local Authorities in April 2013. Following this public health funding has come under 
threat both from the Council wide efficiencies as part of the Government’s debt reduction policy 
and further in-year cuts to Public Health in 2015 (1). For Wakefield Local Authority this equated an 
estimated 20% reduction in the money available to commission public health services between 
2015 and 2020. This has placed pressure on the Council’s ability to fulfil its statutory public health 
responsibilities at previous levels of service delivery (2). 
 
To help minimise the population health impact of spending decisions a clear and transparent 
prioritisation process was designed. This was based on public health outcomes, population need, 
equity of access, current provider performance, best evidence and value for money. It also 
encompassed the political, financial and reputational risks around re-commissioning with a reduced 
budget. The process encompassed three distinct stages.  
 
1. Firstly, public health spend was divided into ten commissioning programmes (e.g. obesity, 
tobacco, sexual health) and their relative importance was ranked using multi-criteria 
decision analysis. 
2. Secondly, each programme was reviewed separately using the Socio-Technical Allocation 
of Resources (STAR) Tool (3) in order to visualise cost effectiveness of elements of each 
programme and provide recommendations to maximise value for money. 
3. Following discussions based on the results of the multi-criteria decision analysis and STAR 
approach, public health commissioning intentions were determined for 2015-2020, with 
services either being re-commissioned, re-designed or de-commissioned.  
 
This paper reports on an experimental use of the STAR Tool for stage 2. STAR is an approach to 
informing value for money analysis of clinical services, which requires three basic sets of data on: 
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costs (fixed costs, costs per case, and numbers of patients treated) and benefits (benefits of typical 
patients) and numbers who benefit from treatment. In STAR these basic sets of data are 
transformed by visual models into information that stakeholders can easily understand.   
 
In STAR there are three visual models for each component of the care pathway: rectangles of total 
costs (fixed and variable); rectangles of total benefits; and value triangles (Figure 1). In the value 
triangle total costs are on the horizontal axis, total benefits on the vertical axis, and value on the 
hypotenuse (i.e. the slope, which gives ratio of benefits to costs). This visual model makes clear 
that components with steep and shallow slopes are better and worse value respectively.  
 
 
 
 
 
 
 
STAR’s fourth visual model, the efficiency frontier, is generated by ordering value triangles in terms 
of their value (slope) for a given use of resources. Components with the highest value tend to be 
those at the start of the care pathway and those with the lowest value at the end. This allows 
illustration of the relative scale of different components in clinical care pathways in terms of their 
costs and benefits (4). Analytic and managerial effort can then be directed at how to reallocate 
resources to improve the value of those care pathways.  
 
 
 
 
Insert Figure 1 Here 
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STAR’s visual models are designed to be used as a basis for discussions on investment and dis-
investment.  These discussions could be based on either ranking or agreed threshold levels of the 
cost effectiveness. Sensitivity analyses around each estimate of local cost effectiveness ratio 
should also be undertaken to inform discussions as there are no definitive estimates of individual 
benefit. While it was originally developed as a tool for clinical services, recent financial challenges 
have presented an opportunity to adapt the tool for prioritisation of public health programmes. We 
report the results of our cost effectiveness analysis of public health services using the STAR Tool 
and the main methodological issues encountered. 
 
Methods 
 
We aimed to produce a STAR efficiency frontier for each of ten local public health programmes: 
sexual health, tobacco control, alcohol, substance misuse, physical activity, obesity, NHS Health 
checks, public mental health, oral health and domestic abuse. For this work a programme was 
defined as an area of commissioning spend covering one area of public health, including one or 
more services; a service was defined as a discrete public health activity with an associated cost. 
To produce an efficiency frontier, costs and benefits needed to be defined for each service within 
the chosen programme.  
 
Identification of Costs 
 
Costs were derived for all commissioned services within a programme from the most recent 
contract value. The cost of each service was averaged over a year and divided by the number of 
individuals accessing each service or component of a service to give an estimate of the cost per 
person. Where numbers accessing services were unavailable, estimates were made from the 
number of individuals offered the service, adjusted by an estimated take up rate. 
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Calculation of Benefit 
 
The design of the STAR Tool when used for analysis of clinical services involves a series of 
stakeholder workshops including commissioners, providers, clinicians and patients to determine 
the estimated individual benefit achieved for individuals benefiting from each intervention; this uses 
assessment of Quality of Life states before and after each intervention. Our experimental public 
health approach to STAR used a modified approach drawing on estimates of benefit in terms of 
Quality-Adjusted Life Years (QALYs) per person from interventions in the economic evaluation 
literature that were comparable to those delivered by the local services.  Where possible UK 
derived QALY estimates with a lifetime horizon were used (5).  These estimates were then 
multiplied by the numbers benefiting to identify the total benefit achieved locally for each service.  
 
Modelling of Uncertainty 
 
Following identification of the initial cost effectiveness estimates, a number of approaches were 
taken to ensure validity of findings. Discussions were held with the relevant local public health 
commissioners to identify whether the results reflected the effectiveness of the local intervention. In 
addition sensitivity analyses were undertaken by entering estimates for all interventions from the 
STAR Tool into a locally developed Microsoft Excel® tool; conservative and optimistic scenario 
estimates derived from halving and doubling the calculated estimate respectively for each 
intervention were plotted on a graph alongside the original intervention estimate to visualise the 
costs and benefits for public health spend for all the relevant commissioning programmes. 
Furthermore, individual cost effectiveness estimates were also triangulated with values from other 
health economic assessment tools for relevant interventions where possible (5).  
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Results 
 
During the application of the STAR tool a number of data problems were encountered, namely a 
lack of detailed contract information, a lack of relevant performance monitoring data, gaps in the 
health economic evidence base, and disparate time horizons. Of the ten public health programmes 
we attempted to model, cost and contract activity data could be sub-divided to allow mapping to 
evidence on the benefits of public health interventions for tobacco control, sexual health, alcohol 
and substance misuse, physical activity, obesity, NHS Health checks and domestic abuse. For 
mental health and oral health, contract data and published evidence were too mismatched to 
produce a STAR tool. We rep rt in detail on two of the programmes, the tobacco control 
programme and alcohol and substance misuse programme, but discuss issues encountered with 
respect to the eight programmes analysed. 
 
Contract activity data 
 
Where contract information was unavailable on the cost of individual components of a service, the 
overall contract was divided by: either the proportion of individuals receiving each component of a 
service, for example the numbers receiving opiate treatment as part of the substance misuse 
service; or the proportion of workforce time delivering each component of a service, for example 
the number of full time equivalent counsellors as a proportion of all staff within the domestic 
violence service. Where it was not possible to subdivide the cost of a service into the costs of the 
components because the latter were delivered simultaneously by one individual, for example the 
health checks, the service was considered as a single entity for the purposes of identifying costs. 
 
It was not straightforward to identify the number of individuals being offered or benefitting from 
some services where there was no directly related performance data, for example mass media 
campaigns around smoking cessation. For these, prevalence figures of the relevant sub group of 
the population being targeted were used as an estimate of numbers receiving the service, for 
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example the proportion of the local population smoking. For other services, an estimate of the 
number of individuals with a condition or behaviour potentially averted was calculated using local 
prevalence data and the latest national yearly increase in incidence of new cases. Other service 
outcome data was used where appropriate to derive estimates, for example trading standards data 
on illicit tobacco seizures was used to derive an estimate of individuals prevented from smoking. 
Where services aimed to train healthcare staff, an estimate was made of the proportion of the local 
population who would benefit as a result of that training, for example services seeking to educate 
primary care staff to better identify victims of domestic abuse. 
 
Benefit estimates  
 
We were not able to extract estimates of QALYs gained per person for some interventions, so the 
following model adjustments were made. Where there was no identifiable cost effectiveness 
estimate for a specific intervention but the evidence base suggested a lack of evidence of 
effectiveness, a near zero QALY value was used. Where there was no identifiable QALY per 
person value for a specific intervention but the evidence base suggested effectiveness, an 
estimate was derived by comparing lifetime QALYs lost for an individual with a condition to an 
individual without it, for example by comparing QALYs lost for a smoker versus a non-smoker and 
applying this to an estimated change in prevalence to find the total QALYS gained. Where a multi-
component service comprised a number of interventions, but there was no single QALY per person 
value for the service as a whole, an average QALY per person value was derived. For example, for 
the health checks service we identified local numbers of new diagnoses for each component of the 
service, and for each diagnosis used estimates of benefit as a result of appropriate further 
management of each from the literature to calculate an average individual benefit for the service as 
a whole. A similar approach was taken for a condom distribution programme, where the total 
number of QALYs gained was calculated based on the QALYs that would be lost for each infection 
that the condom distribution programme was likely to prevent.  
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Time horizon of benefits and costs 
 
Estimates of benefit based on a lifetime horizon were used as a gold standard. Where they were 
unavailable or the time horizon used for the estimate in the evidence base was different from the 
length of follow up for the service, adjustments were made; for example, estimates for weight loss 
interventions from the evidence were based on a lifetime horizon, so were reduced to reflect that 
the service outcomes were measured after three months. Where time horizons differed between 
services within a programme, adjustments were made to reflect lifetime benefit and allow 
comparisons between services. Whilst this was possible for tobacco control, since all services had 
essentially the same desired outcome of permanent quitting, it was not possible for all programmes 
due to the very different nature of the services within them; for example no adjustment was made 
to the estimate for the service aimed at improving the ability of primary care staff to identify 
domestic abuse to allow comparison with the estimate for the domestic abuse counselling service 
which used a different time horizon.  
 
Neither benefits nor costs were discounted over time as there is dispute between economists over 
what the discount rate should be and whether the same rate should be used for costs as well as 
benefits (6). The justification for discounting costs of commodities is that they reduce over time as 
economies become more productive, but as this justification does not apply to well-being, it has 
been argued that it is wrong to discount benefits in QALYs (7). It may also be inappropriate to 
discount costs of health services in austerity as it is unclear that these will be less burdensome in 
future, particularly given health services suffer from Baumol's disease  where labour intensive 
services become relatively more expensive over time (8). An alternative approach would have 
been to discount in line with NICE guidance at an annual rate of 1.5% or that of the United 
Kingdom treasury at 3.5%. 
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Tobacco Control Programme STAR Tool  
 
For the tobacco control programme there were four interventions or services: the specialist 
smoking cessation service, the GP delivered smoking cessation service, and contributions to both 
the West Yorkshire Mass Media Campaign and West Yorkshire Trading Standards, with the 
majority of the funding going to the specialist stop smoking service (Table 1). Mass media 
campaigns and trading standards were estimated to be the most cost effective investments, as 
they reach a far larger population despite having lower estimated benefits per person. GP 
delivered smoking cessation services were estimated to be more cost effective than specialist 
services despite a lower quit rate, as they have lower operating and fixed costs being delivered in-
house (Figure 2). 
 
 
Alcohol and Substance Misuse Programme 
 
For the alcohol and substance misuse programme there were five interventions or services: the 
alcohol and substance misuse treatment and recovery services for opiate use, non-opiate use and 
at-risk alcohol use, an alcohol liaison service, and a support service for parents and carers of those 
with alcohol and substance misuse issues (Table 1). Individual costs of the three treatment 
recovery services were unavailable as they were contained within a single integrated service so an 
assumption was made of equal costs per individual for each component. Opiate treatment and 
recovery accounted for three-quarters of the overall costs of the alcohol and substance misuse 
programme but a third of the estimated benefits. The non-opiate and alcohol addiction recovery 
services were estimated to be the most cost effective components (Figure 3). 
 
 
  
Insert Table 1 Here 
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Table 1: STAR Tool  Analysis for Two Programmes  
 
Service/ 
Intervention 
Cost of 
service per 
year 
Numbers offered 
service each year 
Estimated 
cost per 
person 
Estimated 
% who 
benefit 
Number benefiting 
each year 
Estimated benefit 
per person 
benefiting 
(QALYs) 
Total 
QALYs 
Tobacco Control Programme 
 
Specialist 
smoking 
cessation 
£774,000 2238  
(setting 4 week quit 
date, mean 2013-15) 
 
£345.85 9.2% 207 
(14%(9) of successful 4 
week quitters, mean 
2013-15) 
 
3 
(2.7(10),3.5 (11)) 
 
620 
GP delivered  
smoking 
cessation 
£91,000 1478  
(setting 4 week  quit 
date, mean 2013-15) 
 
£61.57 6.2% 91 
(14% (9) of successful 4 
week quitters, mean 
2013-15) 
 
3 
(2.7 (10),3.5 (11)) 
  
272 
Mass media 
campaign 
 
£50,000  
 
83,000 
(Wakefield 
population who 
smoke) 
 
£0.60 
 
0.4% 166 
(Based on 0.05% 
prevalence decrease in 
smoking prevalence 
0.3-1.1(12),0.44 (13),1.2 
(14),1.6% (15)) 
 
3 
(1.05 (16),2.7(10), 
3.5(11)) 
 
498 
Contribution 
to West 
Yorkshire 
Trading 
Standards 
 
£30,000  
 
83,000 
(Wakefield 
population who 
smoke) 
£0.36 0.04% 30 
(based on Wakefield 
proportional benefits 
(17)) 
3 
(2.7 (10),3.5(11)) 
 
90 
Page 35 of 43
http://jpubhealth.oupjournals.org
Manuscript Submitted to Journal of Public Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 12
 
Service/ 
Intervention 
Cost of 
service per 
year 
Numbers offered service 
each year  
Estimated 
cost per 
person 
Estimated 
% who 
benefit 
Number 
benefiting 
each year 
Estimated benefit 
per person 
benefiting (QALYs) 
Total 
QALYs  
Alcohol and Substance Misuse Programme 
Alcohol and 
substance 
misuse  
recovery 
service  
 
 
 
£4,057,347 
 
 
6548 
(commencing opiate 
treatment, mean 
2015/16) 
 
£524.21 6.2% 408 0.4  
(0.32-0.34 (18), 
0.68-0.71 (19)) 
 
163 
916 
(commencing non-opiate 
treatment, mean 2015/16) 
£524.21 50.7% 464 0.5 
(0.24-0.25 (19), 
0.25 (13), 
0.77-0.79 (16), 
0.38-0.39 (1)) 
 
232 
276 
(commencing alcohol 
treatment 
mean 2015/16) 
 
£524.21 94.2% 260 0.2  
(0.11-0.33 (20)) 
52 
Alcohol liaison 
service 
£95,000 
 
 
1400 
(given brief advice, mean 
2015/16) 
 
£67.86 100% 1400 0.02  
(0.0233 (21) 
0.004-0.018 (22)) 
 
28 
Relatives 
and 
carers 
support 
 
£70,000 
 
312 
(relatives supported, mean 
2015/16)) 
£224.36 100% 312 0.02  
(0.01 (23), 
0.02-0.03 (20)) 
6.3 
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Discussion 
Main finding of this study 
 
This is the first use of the STAR approach to prioritise within public health programmes.  It has 
proved useful in informing commissioning decisions, strategic planning of future provision and 
engaging public health staff in key health economic principles. 
 
Local cost-effectiveness estimates could be made for most interventions, allowing comparison 
within and between programmes using visual methods. In general primary prevention interventions 
were the most cost effective, for example mass media campaigns and trading standards to reduce 
smoking compared to specialist stop smoking services. The visual demonstration of the STAR 
efficiency frontiers helped facilitate discussions on how to increase return on investment in the 
future. The health economic evidence gathered for this work also informed commissioners as to 
how a more targeted and stratified approach may improve the overall cost-effectiveness of the 
public health budget, for example priority target groups within a universal NHS Healthcheck 
programme. Furthermore, most of the local cost-effectiveness estimates suggested existing 
services provided value for money with average cost effectiveness ratios of below £15,000 per 
QALY,. less than the NICE £20,000 threshold for investment for public health interventions. 
 
What is already known on this topic 
 
The STAR tool has previously been used to prioritise competing service bids (24), and to prioritise 
interventions treating patients with eating disorders (25) and chronic obstructive pulmonary disease  
(26). This modified “lean STAR” approach involving only public health commissioners gave further 
guidance at a local level about which particular interventions provided the greatest value for money 
and facilitated communication of this information through graphical means.  
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What this study adds 
 
This work should be seen within the context of the broader interdependencies of public 
health programmes and services. For example, STAR analysis often suggests, as in this 
case, that more ‘upstream’ primary prevention activities (e.g. education, campaigns, 
lifestyle interventions) are more cost-effective than treatment  (such as sexual health and 
opiate addiction treatment).  However it is simplistic to assume that this implies that the 
resources ought to be moved from the latter to the former because there is always a time lag 
from increasing primary prevention to reductions in needs for treatment; also the implications 
of not treating infections or addiction are serious as there is the potential to impact more 
widely on society (crime rates and secondary infections) and demand for other services (A&E 
attendances).  
 
What STAR does is to identify the scale of the resources allocated to different interventions 
and their benefits which may lead into identifying scope for less costly treatment of less 
severe cases that might enable resources to be released for primary prevention. Before any 
re-allocation of resources can occur, assessment of the broader interdependencies of public 
health services within the health, social care and community sector, and the political and 
contractual consequences is necessary, to avoid increasing need in other areas and passing 
costs to other agencies. Any decision making informed by STAR therefore requires careful 
planning and collaboration across the statutory and third sector, especially where there are 
no alternative services. 
 
Limitations of this study 
 
While STAR tools could be produced for most of the programmes, not all of them were sufficiently 
robust to be useful in informing decisions. Limitations were identified with respect to the variable 
evidence base, lack of clearly associated performance monitoring data, and disparate time 
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horizons. Methods were developed to adjust for these issues but ultimately decisions were made 
not to use some estimates: for the mental health programme, which was identified as a priority 
within the district, it was not possible to align the contract data with the published evidence base to 
inform future planning; for the sexual health programme, it was not possible to sub-divide the 
majority of the spend in a meaningful way against published QALY data. As this approach took 
only the commissioner perspective, the perspectives of provider organisations and service users 
might need consideration if the tool is to be used beyond an internal prioritisation exercise.  
 
The locally derived cost effectiveness estimates could also be strengthened by further modelling 
around uncertainty and developing a national online tool to assist local approaches. The latter 
should include evidence based value estimates for individual interventions, with the capacity to add 
locally derived activity and cost data; this would bring a broad health economic evidence base into 
a STAR visualisation tool for public health departments to adapt with local contract and cost data. 
Therefore, allowing for some limitations, this modified STAR approach has the potential to provide 
a useful health economic baseline to inform a broader public health prioritisation process and 
future commissioning arrangements.    
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